Behind the Scenes of Medical Innovation: Spark Biomedical launches new web series ‘Spark a Conversation’
01 Julio 2024 - 8:48AM
For as long as there has been opioid use disorder, there have only
been two solutions: cold turkey or more drugs. The founders of
Spark Biomedical believed there was a better way. Enter: Sparrow
Ascent, a non-invasive wearable neurostimulation device small
enough to fit in your pocket and simple enough your grandpa could
use it. In their new web series, “Spark a Conversation,” Spark
Biomedical, global leaders in wearable neurostimulation technology,
brings you on the revolutionary journey to developing a
21st-century solution to the opioid epidemic.
The series is intended to give physicians,
healthcare business leaders, patients, and caregivers a
behind-the-scenes look into the creation of a medical device
start-up seeking to combat the problem affecting thousands of
patients across the U.S. Viewers will receive answers to essential
questions such as how Sparrow Ascent works and where the idea came
from, empowering them with knowledge and insight into the science
and technology behind Sparrow Ascent directly from the leaders who
are shaping the future of medical technology.
Meet the founders in the first episode: “The
Origin Story,” where you’re invited to join a candid discussion
with Spark Biomedical’s co-founders: Daniel Powell, Chief Executive
Officer; Dr. Alejandro Covalin, Chief Technology Officer; and Dr.
Navid Khodaparast, Chief Science Officer. The trio discusses the
hurdles they’ve overcome and the significant advances that have
been made while pioneering new approaches to opioid withdrawal
treatment.
Episodes are set to rollout July 2024 — launching
with Episodes 1 & 2.
- Episode
1: The Origin Story
- Episode 2: The
Clinical Story
- Episode 3: The Tech
Story
- Episode 4: The
Vision for Sparrow
- Episode 5: Viva Las
Vagus
- Episode
6: Wearable Neurostimulation Story
“Our goal with ‘Spark A Conversation,” says CEO
Daniel Powell, “is to share the knowledge we’ve gathered on our
journey into wearable neurostimulation treatment solutions so that
we demystify what some current patients call ‘magic.’ In our first
season, we dive deep into the background behind our opioid
withdrawal product, Sparrow Ascent. We hope that this level of
candor and information will empower anyone touched by the opioid
epidemic with the knowledge and confidence in a new way
forward.”
Subscribers can watch and/or listen to “Spark a
Conversation” on the Spark Biomedical YouTube channel or
at www.sparkbiomedical.com.
About Spark BiomedicalSpark Biomedical,
Inc. is a leading U.S.-based wearable neurostimulation solutions
developer devoted to the life-saving work of helping 36.3 million
people worldwide overcome withdrawal, heal from addiction, and
achieve the better quality of life they deserve. With
opioid-related misuse and overdose deaths on the rise, the
company’s mission is to eliminate opioid use disorder by working to
address the full lifecycle, including withdrawal management,
opioid-sparing, relapse prevention, and PTSD/trauma abatement.
Spark Biomedical is helping patients take the
first step of overcoming acute opioid withdrawal with its
FDA-cleared wearable technology, the Sparrow Ascent— Transcutaneous
Auricular Neurostimulation (tAN®) for Opioid Withdrawal Relief.
Sparrow Ascent provides an easy, safe, and effective drug-free
treatment option supported by clinical evidence. Next steps are
underway with the launch of two NIDA-funded clinical trials to
improve adult relapse rates and help infants suffering from
Neonatal Opioid Withdrawal Syndrome (NOWS).
For more information, please contact Udim Obot
at udim.obot@sparkbiomedical.com
###
Udim Obot
Spark Biomedical
682-336-0535
udim.obot@sparkbiomedical.com